Showing 14 authorised medicines
Medicine Active substance Licence holder Status
Efavirenz Teva 600 mg film-coated tablets EU/1/11/742/001-010
Efavirenz
Teva B.V. —
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1263/001-002
Tenofovir disoproxil succinate, Efavirenz, Emtricitabine
KRKA, d.d., Novo mesto —
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1222/001-002
Efavirenz, Tenofovir disoproxil maleate, Emtricitabine
Mylan Pharmaceuticals Limited —
Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets PA1986/033/001
Efavirenz, Emtricitabine, Tenofovir disoproxil
Teva B.V. Marketed
Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1210/001
Tenofovir disoproxil phosphate, Efavirenz, Emtricitabine
Zentiva k.s. —
Stocrin EU/1/99/111/003
Efavirenz
Merck Sharp & Dohme BV, —
Stocrin EU/1/99/111/004
Efavirenz
Merck Sharp & Dohme BV, —
STOCRIN EU/1/99/111/001
Efavirenz
Merck Sharp & Dohme BV, —
STOCRIN EU/1/99/111/002
Efavirenz
Merck Sharp & Dohme BV, —
STOCRIN 200 mg film-coated tablets EU/1/99/111/011
Efavirenz
Merck Sharp & Dohme BV, —
STOCRIN 30 mg/mL oral solution EU/1/99/111/005
Efavirenz
Merck Sharp & Dohme BV, —
STOCRIN 50 mg film-coated tablets EU/1/99/111/010
Efavirenz
Merck Sharp & Dohme BV, —
Stocrin Film-Coated EU/1/99/111/6-7
Efavirenz
Merck Sharp & Dohme BV, —
Stocrin Film-Coated EU/1/99/111/8-9
Efavirenz
Merck Sharp & Dohme BV, —
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.